A carregar...

Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study

INTRODUCTION: Rasagiline is a selective, irreversible monoamine oxidase B inhibitor that ameliorates the symptoms of Parkinson’s disease (PD) by inhibiting striatal dopamine metabolism. There is also evidence that monoamine oxidase B inhibitors increase melatonin levels in the pineal gland and may h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuropsychiatr Dis Treat
Main Authors: Schettino, Carla, Dato, Clemente, Capaldo, Guglielmo, Sampaolo, Simone, Di Iorio, Giuseppe, Melone, Mariarosa AB
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5047735/
https://ncbi.nlm.nih.gov/pubmed/27729794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S116476
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!